Stryker Corporation (NYSE:SYK) – Equities research analysts at Oppenheimer Holdings increased their FY2017 earnings estimates for Stryker Corporation in a report issued on Monday. Oppenheimer Holdings analyst S. Lichtman now anticipates that the medical technology company will earn $6.48 per share for the year, up from their prior estimate of $6.46. Oppenheimer Holdings has a “Hold” rating and a $156.00 price objective on the stock. Oppenheimer Holdings also issued estimates for Stryker Corporation’s FY2018 earnings at $7.15 EPS.

Several other research firms have also weighed in on SYK. Cowen and Company set a $166.00 target price on shares of Stryker Corporation and gave the company a “buy” rating in a report on Sunday. Zacks Investment Research raised shares of Stryker Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, October 24th. Robert W. Baird reaffirmed a “hold” rating and set a $161.00 target price on shares of Stryker Corporation in a report on Friday, October 27th. Piper Jaffray Companies reissued a “buy” rating and issued a $156.00 price target on shares of Stryker Corporation in a report on Friday, October 27th. Finally, Wells Fargo & Company boosted their price target on shares of Stryker Corporation from $160.00 to $166.00 in a report on Friday, October 27th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $151.52.

WARNING: This news story was published by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another site, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/11/02/fy2017-earnings-estimate-for-stryker-corporation-issued-by-oppenheimer-holdings-syk.html.

Stryker Corporation (NYSE:SYK) last announced its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.50 by $0.02. The firm had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. Stryker Corporation had a net margin of 14.67% and a return on equity of 24.11%. The company’s revenue for the quarter was up 6.1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.39 earnings per share.

In other Stryker Corporation news, insider Graham A. Mclean sold 1,124 shares of the company’s stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total value of $164,396.24. Following the transaction, the insider now owns 8,983 shares of the company’s stock, valued at $1,313,853.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total transaction of $731,800.00. Following the completion of the transaction, the insider now directly owns 88,207 shares in the company, valued at approximately $12,909,976.52. The disclosure for this sale can be found here. Insiders own 7.40% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. State of Tennessee Treasury Department lifted its position in Stryker Corporation by 18.1% in the third quarter. State of Tennessee Treasury Department now owns 221,528 shares of the medical technology company’s stock valued at $31,462,000 after buying an additional 33,938 shares during the last quarter. Nwam LLC acquired a new position in Stryker Corporation in the third quarter valued at about $228,000. Mn Services Vermogensbeheer B.V. lifted its position in Stryker Corporation by 0.9% in the third quarter. Mn Services Vermogensbeheer B.V. now owns 55,520 shares of the medical technology company’s stock valued at $7,885,000 after buying an additional 500 shares during the last quarter. Old Mutual Global Investors UK Ltd. lifted its position in Stryker Corporation by 2.5% in the third quarter. Old Mutual Global Investors UK Ltd. now owns 52,692 shares of the medical technology company’s stock valued at $7,483,000 after buying an additional 1,298 shares during the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its position in Stryker Corporation by 4.2% in the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 55,051 shares of the medical technology company’s stock valued at $7,818,000 after buying an additional 2,219 shares during the last quarter. 74.00% of the stock is currently owned by institutional investors.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Earnings History and Estimates for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.